Cited 0 time in
Structural mechanism of the antigen recognition by the L1 cell adhesion molecule antibody A10-A3
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Wei, Chun Hua | - |
| dc.contributor.author | Lee, Eung Suk | - |
| dc.contributor.author | Jeon, Jeong Yi | - |
| dc.contributor.author | Heo, Yong-Seok | - |
| dc.contributor.author | Kim, Seung Jun | - |
| dc.contributor.author | Jeon, Young Ho | - |
| dc.contributor.author | Kim, Kyung Hyun | - |
| dc.contributor.author | Hong, Hyo Jeong | - |
| dc.contributor.author | Ryu, Seong Eon | - |
| dc.date.accessioned | 2022-07-16T22:24:05Z | - |
| dc.date.available | 2022-07-16T22:24:05Z | - |
| dc.date.issued | 2011-01 | - |
| dc.identifier.issn | 0014-5793 | - |
| dc.identifier.issn | 1873-3468 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/169298 | - |
| dc.description.abstract | The L1CAM antibody A10-A3 efficiently reduces tumor growth in a nude mouse model. Here, we describe the crystal structure of the Fab fragment of A10-A3 determined at 2.0 angstrom resolution. The A10-A3 antibody H3 loop reveals a characteristic arrangement of exposed aromatic residues that may play an important role in antigen binding. A structure model of the complex between L1CAM Ig1-4 and A10-A3 Fab indicates that the Fab binds to three small loops outside Ig1 and a residue between Ig1 and Ig2, consistent with an epitope mapping result. The data presented here should contribute to the design of high-affinity antibody for therapeutic purposes as well as to the understanding of neural cell remodeling and cancer progression mechanism mediated by L1CAM. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | Structural mechanism of the antigen recognition by the L1 cell adhesion molecule antibody A10-A3 | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1016/j.febslet.2010.11.028 | - |
| dc.identifier.scopusid | 2-s2.0-78650874809 | - |
| dc.identifier.wosid | 000285921500026 | - |
| dc.identifier.bibliographicCitation | FEBS Letters, v.585, no.1, pp 153 - 158 | - |
| dc.citation.title | FEBS Letters | - |
| dc.citation.volume | 585 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 153 | - |
| dc.citation.endPage | 158 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Biophysics | - |
| dc.relation.journalResearchArea | Cell Biology | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Biophysics | - |
| dc.relation.journalWebOfScienceCategory | Cell Biology | - |
| dc.subject.keywordPlus | CRYSTAL-STRUCTURE | - |
| dc.subject.keywordPlus | PROTEIN | - |
| dc.subject.keywordPlus | GROWTH | - |
| dc.subject.keywordPlus | IMMUNOGLOBULINS | - |
| dc.subject.keywordPlus | INHIBITION | - |
| dc.subject.keywordPlus | SUGGESTS | - |
| dc.subject.keywordPlus | SYSTEM | - |
| dc.subject.keywordPlus | FAMILY | - |
| dc.subject.keywordPlus | CANCER | - |
| dc.subject.keywordPlus | MODEL | - |
| dc.subject.keywordAuthor | Crystal structure | - |
| dc.subject.keywordAuthor | Antibody | - |
| dc.subject.keywordAuthor | A10-A3 | - |
| dc.subject.keywordAuthor | L1CAM | - |
| dc.subject.keywordAuthor | Cancer | - |
| dc.identifier.url | https://febs.onlinelibrary.wiley.com/doi/full/10.1016/j.febslet.2010.11.028 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
